Skip to content

Emergency Department Longitudinal Integrated Care

A Longitudinal Collaborative Care Model for Patients With Opioid Problems: Emergency Department Longitudinal Integrated Care (ED-LINC)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03699085
Acronym
ED-LINC
Enrollment
40
Registered
2018-10-09
Start date
2018-12-11
Completion date
2019-12-31
Last updated
2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergency Department, Opioid-use Disorder

Keywords

Opioid Use, Emergency Department, Collaborative Care

Brief summary

The overarching goal of this investigation is to develop and determine the feasibility of a multi-component intervention adapted from a collaborative care framework initiated in the ED for patients at risk for opioid use disorder. This study will provide important feasibility information for future studies of ED-LINC. The collaborative care intervention (ED-LINC) will be supported by a novel Emergency Departement (ED) health information exchange platform.

Detailed description

The overarching goal of this investigation is to develop and determine the feasibility of a multi-component intervention adapted from a collaborative care framework initiated in the ED for patients at risk for opioid use disorder. According to the 2015 national survey on drug use and health, an estimated 3.8 million individuals over 12 years of age were currently misusing opioid pain relievers. An additional 329,000 people use heroin. The Emergency Department (ED) is currently at the forefront of this public health emergency and often a place where patients come for treatment of overdose and for treatment of medical problems related to illicit opioid use. Overall, the goal is to establish the feasibility of a multi-component intervention called 'Emergency Department Longitudinal Integrated Care (ED-LINC)' which is guided by principles of collaborative care and is comprised of components that are evidence-based. ED-LINC is initiated from the ED and continues longitudinally for patients at-risk for opioid use disorder.

Interventions

BEHAVIORALED-LINC

ED-LINC will include 1) A brief negotiated interview at the bedside with an emphasis on motivation to link to services 2) Pharmacotherapy including a discussion of opioid safety, take-home naloxone and initiation of buprenorphine from the ED for participants that are interested and eligible; 3) Longitudinal care management which will proceed for 3-months; and 4) Care plan in the Emergency Department Information Exchange (EDIE) system. This will be coupled with a study cell phone and a weekly supervisory case conference which is consistent with collaborative care principles.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Individuals on the study team designated to conduct follow up interviews will be blinded to which arm participants belong to.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18-65 * Patients with at least one risk factor for opioid use disorder via the EMR pre-screen * Patients with score of ≥ 4 on the NIDA modified ASSIST for illicit opioids (e.g. heroin) OR a score of ≥ 4 on the NIDA modified ASSIST for prescription opioids * Currently have a phone * Able to provide a phone number and one additional piece of contact information

Exclusion criteria

* They are incarcerated or under arrest * Non-English speaking * Live beyond a 50 mile radius of HMC * Require active resuscitation in the ED or other clinical area at the time of RA approach * Are receiving palliative care services or hospice care for a chronic illness such as metastatic cancer * Are in the ED or hospital for a primary psychiatric emergency such as suicidal ideation or attempt * Receiving chronic opioid therapy (COT) defined as prescription opioids for most days out of the last 90 days for a chronic pain condition * In the ED for sexual assault

Design outcomes

Primary

MeasureTime frameDescription
Perception of Care Coordination6 monthsThe Patient Assessment of Chronic Illness Care - Coordination (PACIC-C) questions will be asked of all participants, where greater numbers indicate perception was more coordinated (greater number is better). For the scale, scores must be discrete numbers, with a minimum possible value of 5 and maximum possible value of 25.
Implementation Appropriateness6 monthsParticipants randomized to ED-LINC care were asked about the appropriateness of interventional activities.by rating the agreeability of the statement ED LINC seemed fitting and suitable
ED-LINC Satisfaction6 monthsClient Satisfaction Questionnaire (CSQ-8) questions (8-32) will be used to assess satisfaction with ED-LINC, in which greater numbers designate higher satisfaction (32 is maximum or highest satisfaction rating possible)
Refusal RateBaselinePercentage of subjects who agree to participate in screening survey prior to determining eligibility status. Potential subjects identified by suspected risky substance use history based on EMR review
Follow up Completion Rates6 monthsThe number of participants who completed follow-ups at 6 month time point.
ED-LINC Intervention and Usual Care Process Outcomes6 monthsNumber of participants that received at least 1 ED-LINC element

Secondary

MeasureTime frameDescription
Health Care Utilization6 monthsEmergency department (ED) utilization will be assessed using the Emergency Department Information Exchange (EDIE) .
Substance Use6 monthsComparison between control population and intervention population based on substance use measured utilizing a time-line follow back (TLFB) calendar administered by the research assistant to for past 30-day heroin use at TLFB timepoints (Baseline, 1 month, 3 months, 6 months). Table shows the average of unadjusted TLFB days of Heroin Use with 95% Confidence Interval.

Countries

United States

Participant flow

Pre-assignment details

Baseline survey completed prior to randomization

Participants by arm

ArmCount
ED-LINC Intervention Condition
Patients in this arm will receive the ED-LINC intervention. Elements of ED-LINC are based on evidence-based treatments and are central components of collaborative care. ED-LINC will be supported by a novel Emergency Department Information Exchange (EDIE) technology platform that allows for the creation of ED care plans and electronic alerts and will assist in care coordination of this complex population. ED-LINC: ED-LINC will include 1) A brief negotiated interview at the bedside with an emphasis on motivation to link to services 2) Pharmacotherapy including a discussion of opioid safety, take-home naloxone and initiation of buprenorphine from the ED for participants that are interested and eligible; 3) Longitudinal care management which will proceed for 3-months; and 4) Care plan in the Emergency Department Information Exchange (EDIE) system. This will be coupled with a study cell phone and a weekly supervisory case conference which is consistent with collaborative care principles.
20
Usual Care Condition
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
20
Total40

Baseline characteristics

CharacteristicED-LINC Intervention ConditionTotalUsual Care Condition
Age, Continuous35.5 years
STANDARD_DEVIATION 10.7
37.4 years
STANDARD_DEVIATION 10
39.4 years
STANDARD_DEVIATION 9.3
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants4 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
18 Participants36 Participants18 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Heroin Use19 Participants38 Participants19 Participants
Lifetime Opioid Overdose10 Participants23 Participants13 Participants
Prescription Opioid Misuse6 Participants8 Participants2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants5 Participants4 Participants
Race (NIH/OMB)
More than one race
4 Participants4 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants7 Participants3 Participants
Race (NIH/OMB)
White
11 Participants23 Participants12 Participants
Region of Enrollment
United States
20 participants40 participants20 participants
Sex: Female, Male
Female
8 Participants18 Participants10 Participants
Sex: Female, Male
Male
12 Participants22 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

ED-LINC Intervention and Usual Care Process Outcomes

Number of participants that received at least 1 ED-LINC element

Time frame: 6 months

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Approached SubjectsED-LINC Intervention and Usual Care Process OutcomesAt least 1 ED LINC element received20 Participants
Approached SubjectsED-LINC Intervention and Usual Care Process OutcomesNo ED LINC elements received0 Participants
Usual Care ConditionED-LINC Intervention and Usual Care Process OutcomesAt least 1 ED LINC element received0 Participants
Usual Care ConditionED-LINC Intervention and Usual Care Process OutcomesNo ED LINC elements received20 Participants
Primary

ED-LINC Satisfaction

Client Satisfaction Questionnaire (CSQ-8) questions (8-32) will be used to assess satisfaction with ED-LINC, in which greater numbers designate higher satisfaction (32 is maximum or highest satisfaction rating possible)

Time frame: 6 months

ArmMeasureValue (MEDIAN)
Approached SubjectsED-LINC Satisfaction29 score on a scale
Usual Care ConditionED-LINC Satisfaction30 score on a scale
Primary

Follow up Completion Rates

The number of participants who completed follow-ups at 6 month time point.

Time frame: 6 months

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Approached SubjectsFollow up Completion RatesCompleted 6 month followup18 Participants
Approached SubjectsFollow up Completion RatesNo 6 month followup2 Participants
Usual Care ConditionFollow up Completion RatesCompleted 6 month followup19 Participants
Usual Care ConditionFollow up Completion RatesNo 6 month followup1 Participants
Primary

Implementation Appropriateness

Participants randomized to ED-LINC care were asked about the appropriateness of interventional activities.by rating the agreeability of the statement ED LINC seemed fitting and suitable

Time frame: 6 months

Population: Participants were asked to rate the agreeability of the statement ED LINC seemed fitting and suitable

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Approached SubjectsImplementation AppropriatenessAgreed or Completely Agreed18 Participants
Approached SubjectsImplementation AppropriatenessAnswered OTHER than Agreed or Completely Agreed2 Participants
Primary

Perception of Care Coordination

The Patient Assessment of Chronic Illness Care - Coordination (PACIC-C) questions will be asked of all participants, where greater numbers indicate perception was more coordinated (greater number is better). For the scale, scores must be discrete numbers, with a minimum possible value of 5 and maximum possible value of 25.

Time frame: 6 months

ArmMeasureValue (MEAN)
Approached SubjectsPerception of Care Coordination15 score on a scale
Usual Care ConditionPerception of Care Coordination13 score on a scale
Comparison: Wilcoxon rank-sum test is used, which ranks the values in each group, sums the ranks and determines the probability that they are the same. The probability p-value is reported.p-value: 0.38Wilcoxon (Mann-Whitney)
Primary

Refusal Rate

Percentage of subjects who agree to participate in screening survey prior to determining eligibility status. Potential subjects identified by suspected risky substance use history based on EMR review

Time frame: Baseline

Population: Potential subjects identified by suspected history of risky substance use based on EMR review

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Approached SubjectsRefusal RateRefused Screening Survey5 Participants
Approached SubjectsRefusal RateParticipated in Screening Survey113 Participants
Secondary

Health Care Utilization

Emergency department (ED) utilization will be assessed using the Emergency Department Information Exchange (EDIE) .

Time frame: 6 months

Population: Data was unable to be obtained during the funding period. No data collection of EDIE utilization occurred during this study because team was unable to access EDIE data.

Secondary

Substance Use

Comparison between control population and intervention population based on substance use measured utilizing a time-line follow back (TLFB) calendar administered by the research assistant to for past 30-day heroin use at TLFB timepoints (Baseline, 1 month, 3 months, 6 months). Table shows the average of unadjusted TLFB days of Heroin Use with 95% Confidence Interval.

Time frame: 6 months

ArmMeasureGroupValue (MEAN)Dispersion
Approached SubjectsSubstance UseBaseline18.3 unadjusted TLFB daysStandard Error 2.89
Approached SubjectsSubstance UseMonth 111.95 unadjusted TLFB daysStandard Error 2.95
Approached SubjectsSubstance UseMonth 38.9 unadjusted TLFB daysStandard Error 2.88
Approached SubjectsSubstance UseMonth 613.1 unadjusted TLFB daysStandard Error 2.92
Usual Care ConditionSubstance UseMonth 69.4 unadjusted TLFB daysStandard Error 3.06
Usual Care ConditionSubstance UseBaseline16.85 unadjusted TLFB daysStandard Error 2.8
Usual Care ConditionSubstance UseMonth 312.45 unadjusted TLFB daysStandard Error 3.13
Usual Care ConditionSubstance UseMonth 112.85 unadjusted TLFB daysStandard Error 2.93
Comparison: Comparison of control and intervention populations based on substance use measured utilizing a time-line follow back (TLFB) calendar administered by the research assistant to for past 30-day heroin use. This is a covariate-adjusted mixed effects regression model at TLFB timepoint of 6 months. A number greater than 1.0 indicates a higher incidence of heroin use in the past 30 days at the 6 month timepoint for intervention group compared to control group.p-value: 0.6895% CI: [0.38, 4.37]Regression, Cox

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026